ComErgen Inc. is a research and development company developing a range of technology platforms centered around alternative energy sectors like hydrogen and biodiesel, micro-flow based nanoparticle synthesis for pharmacutical industry and heterogeneous catalysis. Furthermore, ComErgen is a spin-out company of ThalesNano Inc. - itself an innovation led company involved in research into micro and nanoscale chemistry. ThalesNano uses ComErgen hydrogen generating technologies in its R&D100 Award winning H-Cube™, which is revolutionizing the way hydrogenation reactions are performed in the pharmaceutical drug development industry. ComErgen has three divisions, Hydrogen Generation, Nanoparticle Technology and Catalysis. Adopting Thalesnano' microfluidic flow synthesis technology, ComErgen designed nanostructures with controllable shape and size, especially for catalysis and active pharmacutical ingredients in medical applications. The evolvement of the nanoparticle production iniciated the development of high pressure small volume H-Cell for alternative energy industry, chemical industry, mainly pharmaceutical applications as well as for aerospace and defence industry (e.g., drone filling).
Read more
Latest event
Nanosolution 2008
11-13 November 2008, Frankfurt, Germany
www.nanosolutions-frankfurt.de
Upcoming event
2nd Enhanced Solubility & Bioavailibility
9-11 February 2009, Frankfurt am Main, Germany
www.iqpcevents.com
ComErgen's H-Cell electrolyzer represents a profound breakthrough in hydrogen energy that has the potential to greatly expand the possibilities in realizing cleaner, more affordable energy solutions...
Read more
Read more
H-Genie™ is an electrolytic cell based device that produces pure hydrogen on demand at high pressures - in excess of 100 bar (1,500psi) - without the need for a compressor...
Read more
N-Cube™ is a user-friendly bench-top instrument for the rapid synthesis of a wide range of nanostructures (e.g., nobel metals, Quantum Dots, Active Pharmaceutical Ingredients)...
Read more